Research Article
CCL24 Protects Renal Function by Controlling Inflammation in Podocytes
Table 1
Comparison of clinical indicators between diabetic patients without DN and with early DN.
| | Diabetes without DN () | Diabetes with early DN () | |
| | (male/female) | 5/5 | 6/4 | 0.500 | | Age (year) | | | 0.930 | | Urinary microalbumin (mg/L) | | | 0.001 | | Urinary microalbuminuria/urinary creatinine (mg/g) | | | 0.002 | | 24 h urine protein quantitation (g) | | | 0.004 | | Creatinine (μmol/L) | | | 0.001 | | eGFR | | | 0.001 | | Cystatin-C (mg/L) | | | 0.006 | | High-density lipoprotein (mmol/L) | | | 0.727 | | Low-density lipoprotein (mmol/L) | | | 0.72 | | Fasting plasma sugar (mmol/L) | | | 0.15 | | HbA1c (%) | | | 0.26 |
|
|